Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy.

ABSTRACT:

Background

Triple negative breast cancer encompasses several biological entities with different outcomes and is a priority to identify which patients require more treatment to reduce the risk of recurrence and which patients need less treatment.

Patients and methods

Among the 210 women with first primary invasive apocrine non metastatic breast cancer operated on between January 1998 and December 2016 at the European Institute Oncology, Milan, we identified 24 patients with a pT1-pT2, node-negative, triple negative subtype and Ki-67 ≤ 20% who did not receive adjuvant chemotherapy (CT). We compared the outcome of this cohort with a similar group of 24 patients with ductal tumors who received adjuvant chemotherapy, matched by pathological stage and biological features and also

SUBMITTER: Montagna E 

PROVIDER: S-EPMC7424227 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature